Skip to main
CLPT
CLPT logo

CLPT Stock Forecast & Price Target

CLPT Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

ClearPoint Neuro Inc. has demonstrated a strong foundation for growth, achieving a 17% increase in topline revenue while also significantly reducing cash burn, indicating improved profitability. The company's prospects are further bolstered by expected revenue growth of at least 20% in 2024, driven by an expanding partnership base and enhanced service offerings. Additionally, ClearPoint has gained momentum through recent key product approvals and record system installations, which enhance its market position in the medical device sector.

Bears say

ClearPoint Neuro Inc has demonstrated a significant reduction in cash burn throughout 2023, decreasing from $5.8 million in the first quarter to $1.2 million by the fourth quarter. Despite this improvement in controlling expenses, the ongoing reliance on substantial cash outflows raises concerns about the sustainability of its operations. The expectation of continuing this trend into 2024 does not fully address uncertainties surrounding revenue generation and market adoption of its products, which may contribute to a pessimistic outlook for the company's financial health.

CLPT has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Clearpoint Neuro Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Clearpoint Neuro Inc (CLPT) Forecast

Analysts have given CLPT a Strong Buy based on their latest research and market trends.

According to 3 analysts, CLPT has a Strong Buy consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $27.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $27.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Clearpoint Neuro Inc (CLPT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.